Use of mesenchymal cells to modulate immune suppression and immune reconstruction in a patient with aplastic anemia complicated by invasive sino-orbital aspergillosis;Sino-orbital aspergillozisi olan aplastik anemili olguda i̇mmun sistemin baski{dotless}lanmasi{dotless} ve yeniden yapi{dotless}lanmasi{dotless}ni{dotless} saǧlamak amaci{dotless} ile mezenkimal hücrelerin kullani{dotless}mi{dotless}

Turkish Journal of Hematology

Volumn 31, Issue 2, 2014, Pages 180-183

  Özdoǧu, Hakan ^a   Yeral, Mahmut ^a   Boǧa, Can ^a   Kozanoǧlu, Ilknur ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Allogeneic stem cell transplantation; Aplastic anemia; Immune recovery; Mesenchymal stem cell

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; CEFTAZIDIME; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADULT; APLASTIC ANEMIA; ARTICLE; ASPERGILLUS FUMIGATUS; BONE MARROW EXAMINATION; CASE REPORT; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; CYTOMEGALOVIRUS; ECCHYMOSIS; EPSTEIN BARR VIRUS; ERYTHEMA; ETHMOID SINUS; FEVER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NASAL DISCHARGE; NEUTROPHIL COUNT; NOSE DISEASE; PANCYTOPENIA; PERIORBITAL EDEMA; PERIORBITAL ERYTHEMA; PERIORBITAL PAIN; PETECHIA; SEROLOGY; SINO ORBITAL ASPERGILLOSIS; THROMBOCYTE COUNT;

EID: 84905908911     PISSN: 13007777     EISSN: 13085263     Source Type: Journal    
DOI: 10.4274/tjh.2013.0041     Document Type: Article

References (13)

1. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol 2001;29:259-277
2. Damodar S. Allogeneic stem cell transplant in a patient with aplastic anemia with bacteremia and candidemia. Turk J Hematol 2008;25:209-210
3. Koç ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307-316
4. Meuleman N, Tondreau T, Ahmad I, Kwan J, Crokaert F, Delforge A, Dorval C, Martiat P, Lewalle P, Lagneaux L, Bron D. Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev 2009;18:1247-1252
5. Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev 2006;20:161-171
6. Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S, Ibatici A, Del Bono V, Bacigalupo A, Viscoli C. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009;44:361-370
7. McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P, Marin P, Nissen C, Van't Veer Kerthof E, Raghavachar A, Socie G, Frickhofen N, Locasciulli A, Schrezenmeier H. Graft rejection and second bone marrow transplants for acquired aplastic anemia: a report from the Aplastic Anemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 1994;13:233-237
8. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, Ljungman P, Lönnies H, Nava S, Ringdén O. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007;21:1733-1738
9. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441
10. Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus host disease. Transplantation 2006;81:1390-1397
11. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F, Fibbe WE. Cotransplantation of ex vivo expanded mesenchymal stem cells failure accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007;110:2764-2767
12. Zhang X, Jiao C, Zhao S. Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev 2009;5:402-409
13. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-1586.